Medgend Icon

Ledgend of Medicine







discontinued


Dexmethylphenidate Hydrochloride FDA Approved Drugs

DEXMETHYLPHENIDATE HYDROCHLORIDE [Dexmethylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral tablet)
15mg (oral capsule, extended release)
2.5mg (oral tablet)
20mg (oral capsule, extended release)
25mg (oral capsule, extended release)
30mg (oral capsule, extended release)
35mg (oral capsule, extended release)
40mg (oral capsule, extended release)
Abhai IncDec 4, 2015
Impax Labs IncAug 5, 2015
Mylan Pharms IncAug 25, 2015
Novel Labs IncDec 4, 2015
Par Pharm IncNov 30, 2016
Sun Pharm IndsSep 24, 2015
Teva PharmsJan 29, 2007
Teva Pharms UsaNov 19, 2013
Tris Pharma IncAug 26, 2016
IntellipharmaceuticsNov 18, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FOCALIN [Dexmethylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral tablet)
2.5mg (oral tablet)
NovartisNov 13, 2001
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FOCALIN XR [Dexmethylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral capsule, extended release)
15mg (oral capsule, extended release)
20mg (oral capsule, extended release)
25mg (oral capsule, extended release)
30mg (oral capsule, extended release)
35mg (oral capsule, extended release)
40mg (oral capsule, extended release)
NovartisMay 26, 2005
  • Method of treating attention deficit disorder using oral administration of a bi-modal or pulsatile release composition.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.